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Abstract We have characterized the genomic structure of
12.3 kb of the 5P-flanking region of the human histamine H2
receptor gene. The multiple transcription initiation sites of the
human histamine H2 receptor gene were mapped utilizing the
5P-end cap structure of mRNA. We found that a 85 bp segment
(3610^3525 bp) immediately upstream of the initiation site
exhibits a strong promoter activity in the gastric adenocarcino-
ma, MNK45, expressing human histamine H2 receptor. A 4.8 kb
transcript of the human histamine H2 receptor gene was found in
the placenta, spinal cord, lymph node and bone marrow in
addition to the previously reported tissues including the heart,
brain and stomach, whereas a 1.8 kb transcript was observed in
almost all tissues examined. 3P-rapid amplification of cDNA ends
revealed the corresponding length of the 3P-untranslated region.
These results suggest that the 3P-untranslated region may be
involved in the differential expression.
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1. Introduction
Histamine, a ubiquitous chemical mediator, has a wide
range of biological actions including in£ammation, contrac-
tion of smooth muscles, dilation of capillaries and stimulation
of gastric acid secretion. These e¡ects are mediated by one or
combinations of the three pharmacologically de¢ned receptor
subtypes, named H1, H2 and H3 [1]. Studies with antagonists
have demonstrated the importance of the H2 receptor (H2R)
in the regulation of gastric acid secretion, contraction of the
heart, gastrointestinal motility, cell di¡erentiation and cell
proliferation [2]. The histamine H2R gene has been cloned
from man [3], dog [4], rat [5], mouse [6] and guinea pig [7]
and the transcripts were detected in the brain and stomach.
Detailed histochemical studies revealed that H2R is localized
in gastric parietal cells and enteric neurons [8].
To understand the transcriptional regulation of H2R, we
have analyzed the genomic structure of the 12.3 kb 5P-£anking
region of the human H2R gene. By using the oligo-capping
method, that traps the cap structure on the 5P-end of full
length mRNA [9^11], we found that H2R contains multiple
transcription initiation sites. Corresponding mRNAs were de-
tected in various tissues. An 85 bp segment upstream of the
transcription initiation sites showed a strong TATA-less pro-
moter activity and was responsible for transcripts starting
from 3409 or 3367 bp.
2. Materials and methods
2.1. Cell culture and characterization of a human H2R genomic clone
A poorly di¡erentiated human gastric adenocarcinoma cell line,
MKN45 (from the Japanese Cancer Research Resources Bank) [13],
was cultured at 37‡C in RPMI 1640 medium containing 10% fetal calf
serum.
A human histamine H2R clone [12] was subcloned into the pBlue-
script plasmid. Sequencing was performed with either pUC/M13 for-
ward and reverse primers or sequence-speci¢c oligonucleotide primers
using a Perkin Elmer-Applied Biosystems 377 Automated Sequencer.
2.2. Oligo-capping analysis
Poly (A) RNA was puri¢ed using oligo-dT latex beads (Oligotex-
dT30 Super, TaKaRa) from RNA isolated with a QuickPrep Total
RNA Extraction kit (Amersham Pharmacia Biotech). Oligo-capping
was performed as described by Maruyama and Sugano [9^11] with
some modi¢cations. The poly (A) RNA was treated with bacterial
alkaline phosphatase (TaKaRa) and tobacco acid pyrophosphatase
(Epicentre Technologies) and then ligated with an RNA oligonucleo-
tide (R-OLIGO, Table 1) using RNA ligase (TaKaRa). After each
step, the reaction mixture was subjected to phenol/chloroform extrac-
tion and then, the RNA was precipitated with ethanol. The oligo-
capped RNA was ¢nally converted to cDNA with Superscript II
reverse-transcriptase (Gibco) and a NotI poly dT primer adapter
(Clontech).
cDNA was ampli¢ed by PCR with the D-OLIGO30 and H2REC-
GSP1 primers (Table 1) and the products were subjected to second-
round PCR with D-OLIGO30 and H2REC-GSP2 (Table 1). The
products separated by polyacrylamide gel electrophoresis were se-
quenced with the nested primer, H2REC-GSP2.
2.3. Construction of promoter/reporter fusion plasmids and transient
transfection
Reporter plasmid pGVH2L2D carries the 3610^3278 bp region of
the H2R gene in front of the luciferase gene of the PGV-B vector
(Toyo Ink) [12]. Deletion derivatives were constructed using appro-
priate restriction enzymes.
45 h after transfection of the plasmids by electroporation, the cells
were rinsed twice with phosphate-bu¡ered saline and then lysed in cell
lysis reagent PGC-50 (Toyo Ink). Extracts were mixed with a sub-
strate solution (PGL-1500, Toyo Ink) and then, the light intensity was
measured with a luminometer, Lumat LB 9501 (Berthod). The pGV-B
vector lacking the eukaryotic promoter and enhancer and pGV-C
carrying the SV40 promoter and enhancer were used as controls. Cells
transfected with a given construct were assayed in triplicate and ex-
pression of the co-transfected pact-L-gal plasmid (NipponGene) was
used to correct the transfection e⁄ciency.
2.4. 3P-RACE analysis and Northern blot analysis
Full length cDNA was obtained from the poly (A) RNA with
Superscript II reverse-transcriptase (Gibco) and a NotI poly dT
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primer adapter. H2REC-GSP12 (Table 1) and a NotI poly dT primer
adapter were used for the ¢rst-round PCR and a part of the product
was used for the second-round PCR with a nested primer, H2REC-
GSP13 (Table 1) and a NotI poly dT primer adapter. The second PCR
product was subjected to polyacrylamide gel electrophoresis and then
blotted to a Hybond-N membrane (Amersham Pharmacia Biotech).
The blot was hybridized with a £uorescein-labelled probe (‘probe 3’,
Fig. 1B) corresponding to the 3P-£anking region of the H2R gene. The
PCR products hybridized with the H2R gene-speci¢c probe were se-
quenced using H2REC-GSP13.
A 1.1 kb NcoI fragment of pHISH2R containing the entire open
reading frame of H2R was used as a probe (‘probe 1’, Fig. 1B).
Human L-actin cDNA was obtained from Clontech. Hybridization
with human multiple tissue Northern blot I and III (Clontech) was
carried out as recommended by the manufacturer. Radioactive bands
were visualized with a Fuji Film BAS 1000.
3. Results and discussion
3.1. The 12.3 kb sequence of the human histamine
H2R gene
A Vgt11 clone containing the 12.3 kb 5P-upstream region,
1080 bp coding region and 245 bp 3P-downstream sequence of
H2R was isolated from a human genomic library [12] (Fig.
1A). We determined the entire upstream sequence (accession
number AB023486), but found no homology with those de-
posited in the GenBank and EST databases.
3.2. Multiple transcription initiation sites of the human
histamine H2 receptor gene
No information on transcription initiation sites is available
for H2R genes, although they have been cloned from various
species [3^7]. Because the proximal promoter region lacks an
apparent TATA box, it is possible that the H2R gene has
multiple transcription initiation sites. To unambiguously iden-
tify the transcription start sites, we applied the oligo-capping
method, that speci¢cally replaces the 5P-cap structure of
mRNA with a synthetic RNA oligonucleotide (R-OLIGO)
[9^11]. cDNA with an oligo sequence at the 5P-end was am-
pli¢ed with D-OLIGO30 and H2R gene-speci¢c primers. As
shown in Fig. 2A, seven major PCR products (numbers 1^7)
were obtained. Southern analysis con¢rmed that six of them
(numbers 2^7) were H2R gene-speci¢c (data not shown). The
60 bp fragment (number 1) was a primer-dimer. The six bands
(numbers 2^7) were eluted and sequenced directly. Compari-
son of the genomic and PCR product sequences revealed that
band numbers 2, 4, 5 and 7 contained the same initiation site
starting at 3367 bp (Fig. 2B). The di¡erences in electropho-
retic mobility were due to the tandem repeat of the R-OLIGO
ligated at the 5P-end or secondary structural di¡erences of
single-stranded PCR products. The band number 3 started
from 3409 bp (Fig. 2B). The H2R gene expressed in either
MKN45 (Fig. 2A) or HL60 cells (data not shown) exhibited
the same initiation sites. These two initiation sites were lo-
cated within the BglII^BstXI region (Fig. 3).
A short 58 bp sequence (accession number AB023487) was
found between the R-OLIGO and the sequence of the H2R
transcript starting from 3525 bp (number 6, Fig. 2A). The
Table 1
Primers used in this study
Name Sequence (5P to 3P)
R-OLIGO AGC AUG GAG UCG GCC UUG UUG GCC UAC UGG
NotI poly dT
primer adapter
AAT TCG CGG CCG CTT TTT TTT TTT TTT T
D-OLIGO30 AGC ATC GAG TCG GCC TTG TTG GCC TAC TGG
H2REC-GSP1 GTG GGG AAG GCT TCA TAG ACT GAC
H2REC-GSP2 AGT CCT CAG ACG GTC CCC TGA A
H2REC-GSP12 GTC CAA CGC CTC TCA GCT GTC CA
H2REC-GSP13 CCC TAG CCA TTG GTG CAC AGG ATG
Fig. 1. H2R gene structure and transcription initiation. A: Restriction enzyme map of the H2R gene. The ¢lled box indicates the encoding re-
gion. B: The 2.0 kb BglII^EcoRI fragment. The positions of transcription initiation site and splicing acceptor site are shown by arrows and an
asterisk, respectively. ‘AAA’ indicates the putative polyadenylation site. The primers used for oligo-capping or 3P-RACE analysis (also see Ta-
ble 1) and the probes used for Northern (probe 1, +1^+1080 bp) or Southern blot (probe 2, 3421^3292 bp; probe 3, +1084^+1230 bp) analy-
sis are indicated. The predicted sizes of H2R transcripts (1.8 kb and 4.8 kb) are also indicated.
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inserted sequence showed no homology with the 12.3 kb
5P-upstream or other known sequences registered in the
DNA databases. The 58 bp sequence inserted at the same
position in the H2R mRNA was also found with the 5P-
RACE method (data not shown). It is possible that the 58
bp sequence is an exon of the H2R gene existing upstream the
12.5 kb 5P-£anking region. Actually, ‘AG’, a splice consensus
sequence, was found immediately upstream at 3525 bp. In
order to investigate the origin of the 58 bp sequence, we
performed long and accurate PCR using human genomic
DNA as template, with primers corresponding to the 58 bp
and the 5P-region of the isolated H2R gene, respectively. This
result strongly suggested that the 58 bp sequence is an exon of
the H2R gene, existing upstream of an approximately 19 kb
intron. Further study on the 58 bp sequence and its promoter
region is currently in progress.
It has recently been reported that the human histamine H1
receptor contains an intron of approximately 5.8 kb and a
short 150 bp exon encoding 5P-untranslated region (UTR),
suggesting that the histamine receptor subfamily of G-pro-
tein-coupled receptors may contain an intron [14].
3.3. Essential promoter region required for transcription within
the BglII^BstXI region
We have reported that a 5P-£anking region (BglII^BstXI)
exhibited promoter activity in MKN45 cells [12]. To identify
the essential promoter, we constructed a series of deletions
and subjected them to a reporter gene assay. The BglII^BstXI
Fig. 2. Determination of the transcription start sites of the H2R gene. A: PCR was performed with the D-OLIGO30 and H2REC-GSP2
primers. M: DNA marker (100 bp ladder, Gibco). No speci¢c PCR product was detected when the PCR reaction was performed without either
primer. Southern analysis with probe 2 (Fig. 1B) showed that product numbers 2^7 were H2R-speci¢c. B: The initiation sites were determined
by direct sequence analysis of the PCR products eluted from a polyacrylamide gel and the transcription initiation sites and splicing acceptor
site are indicated by arrows and an asterisk, respectively.
Fig. 3. Essential region for the promoter activity of the H2R gene. A series of deletions of the BglII^BstXI region of the H2R gene was ligated
in front of the luciferase gene (luc), followed by transfection into MKN45 cells. The positions of transcription initiation site are indicated. The
direction of the BglII^AlwNI fragment in the reporter constructs is shown by arrows. The normalized luciferase activities with the S.D.s are rel-
ative to the activity of the BglII^BstXI region.
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fragment showed a signi¢cantly high transcription activity
(Fig. 3), con¢rming previous results [12]. However, transcrip-
tion was essentially lost when the BglII^AlwNI segment
(85 bp), upstream of the initiation sites, was deleted. The
85 bp segment could support transcription, with a similar
activity to that of the BglII^BstXI region, but its activity
was completely lost when it was ligated in the reverse direc-
tion (Fig. 3, bottom). Essentially the same results were ob-
tained with other human cell lines, such as HeLa, HL60 and
293 cells (data not shown), suggesting that the 85 bp segment
exhibits an ubiquitous promoter activity.
3.4. Human H2R transcripts exhibit a wide tissue distribution
Northern analysis using probe 1 (Fig. 1B) revealed a 4.8 kb
transcript in the heart, brain and stomach, as previously re-
ported in dog and rodents [4^7] (Fig. 4A, arrowheads). In
addition, the transcript was detected in the placenta, spinal
cord, lymph node and bone marrow, although the level of
expression was variable. It would be interesting to know the
physiological functions of H2R in these tissues.
Furthermore, a 1.8 kb transcript was found in almost all
tissues examined, with a relatively high expression level. Since
the length of 3P-UTR of H2R from man or other species is
not clear, we performed 3P-RACE and analyzed the PCR
products. Southern analysis with a probe corresponding to
the 3P-£anking region (‘probe 3’, Fig. 1B) gave four major
bands (0.3, 0.5, 1.0 and 3.0 kb, Fig. 4B). We have determined
the sequence of the 0.3 kb fragment (Fig. 4C) and found that
the position of polyadenylation was at +1404 bp. The 0.3 kb
or 0.5 kb 3P-UTR, combined with the transcription initiation
sites described above, predicts a total mRNA length of ap-
proximately 1.8 kb, which corresponds nicely with the size of
the smaller transcript identi¢ed on Northern blot analysis. In
the same way, the 3.0 kb 3P-UTR accounts for the 4.8 kb
Fig. 4. Transcripts of the H2R gene. A: H2R mRNA in various tissues. Poly (A) RNAs (2 Wg/lane) from human adult tissues were probed
with the encoding region of the human H2R (probe 1, Fig. 1B) or a human L-actin cDNA. The positions of markers and hybridized transcripts
(arrowheads) are indicated. B: Southern analysis of the 3P-RACE products. Size of the products hybridized with the probe 3 (Fig. 1B), covering
the 3P-£anking region, are indicated. C: The sequence of the 0.3 kb 3P-UTR. The 3P-downstream sequence not found in the genomic clone is
shown in bold letters and the polyadenylation site is indicated by an asterisk.
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transcript. The transcript corresponding to the 1.0 kb 3P-UTR
was also detected weakly in several tissues (Fig. 4A). These
results suggest that the di¡erence in 3P-UTR of H2R may be
involved in its di¡erential expression. The possible roles of
H2R in the regulation of cell growth and di¡erentiation
have been suggested recently [15^17]. The relationship be-
tween the broad expression range of the 1.8 kb transcript
and the potential role of H2R in cell proliferation is an inter-
esting possibility to be studied.
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